Vor Biopharma Inc

Call
Website
100 Cambridgepark Dr Ste 101
Cambridge, MA 02140
+1 (617) 655-6580
https://www.vorbio.com

Vor Biopharma Inc. is a clinical-stage biotechnology company based in Cambridge, MA, dedicated to transforming the treatment of autoimmune diseases. The company is advancing telitacicept, a novel dual-target recombinant fusion protein that targets key cytokines involved in B cell survival and autoantibody production, aiming to provide life-changing therapies for patients worldwide.

With its leadership team, including CEO Jean-Paul Kress, M.D., and Chief Financial Officer Sandy Mahatme, Vor Bio is focused on the development and commercialization of innovative treatments. Telitacicept has already received approval in China for conditions such as generalized myasthenia gravis and systemic lupus erythematosus, and a global Phase 3 clinical trial is currently underway to support its approval in the United States and Europe.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Boston Cancer Policy Institute Inc

Boston Cancer Policy Institute Inc is dedicated to advancing research programs aimed at improving cancer policy and patient outcomes. The institute invites inquiries regarding its initiatives and is committed to providing timely responses to those who reach out. With a focus on innovative approaches within the oncology field, the institute plays a vital role in shaping cancer policy. It operates under a framework that emphasizes collaboration and knowledge sharing among researchers and practitioners. Generated from the website
Sizes, Business services, nec, nec

Blueprint Medicines

Blueprint Medicines, based in Cambridge, MA, is dedicated to transforming groundbreaking science into innovative therapies that significantly improve patient lives. With a strong focus on allergic inflammatory diseases and cancer, the company seeks to pioneer novel solutions by targeting the root causes of disease through a diverse and passionate team. Their commitment to accelerating the development of new treatments is reflected in their robust pipeline and dedication to clinical research. By fostering a collaborative environment that values diversity and bold decision-making, Blueprint Medicines aims to revolutionize the medical landscape and extend the time patients can enjoy with their loved ones. Generated from the website
Dana-Farber Cancer Institute
Business services, nec, nec, Psychiatrists and psychoanalysts, Services, nec, nec

Dana-Farber Cancer Institute

15
•
$
"First time here today for breakfast. Lots of great options. I had a breakfast sandwich that was excellent. Fresh made on croissant. The other station had 7-10 options to grab and make a..."
photo of C. T.
United States›Massachusetts›Cambridge›Vor Biopharma Inc

Partial Data by Infogroup (c) 2025. All rights reserved.